High GAD65 autoantibody levels in nondiabetic adults are associated with HLA but not with CTLA-4 or INS VNTR

Journal of Internal Medicine

Volumn 253, Issue 4, 2003, Pages 447-453

  Rolandsson, Olov ^a   Hagg E ^a   Janer, M ^b   Rutledge, E ^c   Gaur, L K ^c   Nilsson, M ^a   Hallmans, G ^a   Lernmark, A ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmunity; Glutamate decarboxylase; Human leucocyte antigen; Sex; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE ANTIBODY; LEUKOCYTE ANTIGEN;

ADULT; ADULTHOOD; ALLELE; ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; CALCULATION; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HEALTH PROGRAM; HUMAN; HYBRIDIZATION; IMMUNOASSAY; MALE; MOLECULAR WEIGHT; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; RANDOMIZATION; RISK ASSESSMENT; SEX RATIO; SWEDEN; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; IMMUNOCONJUGATES; INSULIN; MALE; MIDDLE AGED; MINISATELLITE REPEATS; ODDS RATIO; RADIOLIGAND ASSAY;

EID: 0345701218     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01115.x     Document Type: Article

References (38)

1. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9.
2. Yu L, Robles DT, Abiru N et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000; 97: 1701-6.
3. Rabin DU, Pleasic SM, Shapiro JA et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994; 152: 3183-8.
4. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase. IA-2. from human insulinoma. DNA Cell Biol 1994; 13: 505-14.
5. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase [published erratum appears in Nature 1990 October 25; 347 (6295): 782]. Nature 1990; 347: 151-6.
6. Karlsen AE, Hagopian WA, Grubin CE et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci U S A 1991; 88: 8337-41.
7. Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today 1990; 11: 122-9.
8. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 1995; 92: 8560-5.
9. She JX, Matron MP. Genetic susceptibility factors in type 1 diabetes: linkage, disequilibrium and functional analyses. Curr Opin Immunol 1998; 10: 682-9.
10. Concannon P, Gogolin Ewens KJ, Hinds DA et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998; 19: 292-6.
11. Landin-Olsson M, Palmer JP, Lernmark Å et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068-73.
12. Braciale TJ, Braciale VL. Antigen presentation: structural themes and functional variations. Immunol Today 1991; 12: 124-9.
13. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res 2001; 56: 5669-89.
14. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33: 176-83.
15. Bennett ST, Lucassen AM, Gough SC et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-92.
16. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5: 1075-80.
17. N-repeat affects risk for type 1 diabetes. Autoimmunity 2000; 32: 173-80.
18. Linsley PS, Golstein P, Lymphocyte activation: T-cell regulation by CTLA-4. Curr Biol 1996; 6: 398-400.
19. Pugliese A, Zeller M, Fernandez A et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15: 293-7.
20. Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15: 289-92.
21. Graham J, Hagopian WA, Kockum I et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346-55.
22. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
23. Kumar D, Gemayel NS, Deapen D et al. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993; 42: 1351-63.
24. Rolandsson O, Hägg E, Hampe C et al. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibody index in a regional population is related to glucose intolerance and body mass index. Diabetologia 1999; 42: 555-9.
25. Rolandsson O, Hägg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark Å. Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J Intern Med 2001; 249: 279-88.
26. Falorni A, Örtqvist E, Persson B, Lernmark Å. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Meth 1995; 186: 89-99.
27. Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-50.
28. Verge CF, Stenger D, Bonifacio E et al. Combined use of autoantibodies (IA-2 autoantibody. GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial Islet Autoantibody Workshop. Diabetes 1998; 47: 1857-66.
29. Leech NJ, Kitabchi AE, Gaur LK et al. Genetic and immunological markers of insulin dependent diabetes in Black Americans. Autoimmunity 1995; 22: 27-32.
30. Gleichmann H, Zorcher B, Greulich B et al. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 1984; 27: 90-2.
31. Julier C, Hyer RN, Davies J et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991; 354: 155-9.
32. Undlien DE, Bennett ST, Todd JA et al. Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes 1995; 44: 620-5.
33. Sanjeevi CB, Falorni A, Kockum I, Hagopian WA, Lernmark Å. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 209-17.
34. Vandewalle CL, Falorni A, Lernmark Ået al. Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry, Diabetes Care 1997; 20: 1547-52.
35. Gale EAM, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44: 3-15.
36. Weets I, Van Autreve J, Van der Auwera BJ et al. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia 2001; 44: 40-7.
37. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M. DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80: 41-5.
38. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 2001; 86: 1687-93.